Influence of Nanoparticles on Blood–Brain Barrier Permeability and Brain Edema Formation in Rats

  • Hari Shanker SharmaEmail author
  • Saber Hussain
  • John Schlager
  • Syed F. Ali
  • Aruna Sharma
Conference paper
Part of the Acta Neurochirurgica Supplementum book series (NEUROCHIRURGICA, volume 106)


Nanoparticles are small sized (1–100 nm) particles derived from transition metals, silver, copper, aluminum, silicon, carbon and metal oxides that can easily cross the blood–brain barrier (BBB) and/or produce damage to the barrier integrity by altering endothelial cell membrane permeability. However, the influence of nanoparticles on BBB integrity is still not well-known. In this investigation, effect of nanoparticles derived from Ag, Al and Cu (50–60 nm) on BBB permeability in relation to brain edema formation was examined in a rat model. Intravenous (30 mg/kg), intraperitoneal (50 mg/kg) or intracerebral (20 µg in 10 µL) administration of Ag, Cu or Al nanoparticles disrupted the BBB function to Evans blue albumin (EBA) and radioiodine in rats 24 h after administration and induced brain edema formation. The leakage of Evans blue dye was observed largely in the ventral surface of brain and in the proximal frontal cortex. The dorsal surfaces of cerebellum showed mild to moderate EBA staining. These effects were most pronounced in animals that received Ag or Cu nanoparticles compared to Al nanoparticles through intravenous routes. These observations are the first to suggest that nanoparticles can induce brain edema formation by influencing BBB breakdown in vivo.


Nanoparticles silver copper aluminum blood–brain barrier brain edema Evans blue radioiodine 



This investigation is partially supported by the Air Force Office of Scientific Research (London), Air Force Material Command, USAF, under grant number FA8655-05-1-3065. The U.S. Government is authorized to reproduce and distribute reprints for Government purpose notwithstanding any copyright notation thereon. The views and conclusions contained herein are those of the authors and should not be interpreted as necessarily representing the official policies or endorsements, either expressed or implied, of the Air Force Office of Scientific Research or the U.S. Government. We express sincere gratitude to several laboratories where a part of the work is done or some data is recorded and evaluated. Financial support from Acure Pharma (Sweden); Astra-Zeneca, Mölndal, Sweden, Alexander von Humboldt Foundation (Germany); The University Grants Commission, New Delhi, India, Department of Science and Technology, Govt. of India, New Delhi is gratefully acknowledged. The authors have no conflict of interest with any financial agencies mentioned above. Technical assistance of Inga Hörte, Kerstin Flink, Madeleine Jarild, Mari-Anne Carlsson, Margaretta Butler of Uppsala University are highly appreciated.


  1. 1.
    Crüts B, van Etten L, Törnqvist H, Blomberg A, Sandström T, Mills NL, Borm PJ (2008) Exposure to diesel exhaust induces changes in EEG in human volunteers. Part Fibre Toxicol Mar 11; 5:4Google Scholar
  2. 2.
    Elder A, Gelein R, Silva V, Feikert T, Opanashuk L, Carter J, Potter R, Maynard A, Ito Y, Finkelstein J, Oberdörster G (2006) Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ Health Perspect 114:1172–1178PubMedCrossRefGoogle Scholar
  3. 3.
    Kim JS, Yoon TJ, Yu KN, Kim BG, Park SJ, Kim HW, Lee KH, Park SB, Lee JK, Cho MH (2006) Toxicity and tissue distribution of magnetic nanoparticles in mice. Toxicol Sci Jan; 89(1):338–347. Epub 2005 Oct 19. Erratum in: Toxicol Sci. Mar 2006; 90(1):267Google Scholar
  4. 4.
    Kiyatkin EA, Brown PL, Sharma HS (2007) Brain edema and breakdown of the blood–brain barrier during methamphetamine intoxication: critical role of brain hyperthermia. Eur J Neurosci Sep 26(5):1242–1253CrossRefGoogle Scholar
  5. 5.
    Kreuter J (2007) Nanoparticles – a historical perspective. Int J Pharm Feb 22; 331(1):1–10Google Scholar
  6. 6.
    Oberdörster G, Sharp Z, Atudorei V, Elder A, Gelein R, Kreyling W, Cox C (2004) Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol 16:437–445PubMedCrossRefGoogle Scholar
  7. 7.
    Rapoport SI, Hori M, Klatzo I (1971) Reversible osmotic opening of the blood–brain barrier. Science Sep 10; 173(4001):1026–1028Google Scholar
  8. 8.
    Rogers EJ, Bello D, Hsieh S (2008) Oxidative stress as a screening metric of potential toxicity by nanoparticles and airborne particulate matter. Inhal Toxicol Jul; 20(9):895CrossRefGoogle Scholar
  9. 9.
    Sharma HS (2007) Nanoneuroscience: emerging concepts on nanoneurotoxicity and nanoneuroprotection. Nanomed Dec; 2(6):753–758. EditorialGoogle Scholar
  10. 10.
    Sharma HS (1987) Effect of captopril (a converting enzyme inhibitor) on blood–brain barrier permeability and cerebral blood flow in normotensive rats. Neuropharmacology 6(1):85–92CrossRefGoogle Scholar
  11. 11.
    Sharma HS, Dey PK (1986) Influence of long-term immobilization stress on regional blood–brain barrier permeability, cerebral blood flow and 5-HT level in conscious normotensive young rats. J Neurol Sci 72(1):61–76PubMedCrossRefGoogle Scholar
  12. 12.
    Sharma HS, Sjöquist PO (2002) A new antioxidant compound H-290/51 modulates glutamate and GABA immunoreactivity in the rat spinal cord following trauma. Amino Acids 23(1–3):261–272PubMedCrossRefGoogle Scholar
  13. 13.
    Sharma HS, Sharma A (2007) Nanoparticles aggravate heat stress induced cognitive deficits, blood–brain barrier disruption, edema formation and brain pathology. Prog Brain Res 162:245–273. ReviewGoogle Scholar
  14. 14.
    Sharma HS, Westman J, Cervós-Navarro J, Nyberg F (1997) Role of neurochemicals in brain edema and cell changes following hyperthermic brain injury in the rat. Acta Neurochir Suppl 70:269–274PubMedGoogle Scholar
  15. 15.
    Sharma S, Ali SF, Hussain SM, Schlager JJ, Sharma A (2009) Influence of Engineered Nanoparticles from Metals on the Blood-Brain Barrier Permeability, Cerebral Blood Flow, Brain Edema and Neurotoxicity. An Experimental Study in the Rat and Mice Using Biochemical and Morphological Approaches. J Nanosci Nanotechnol 9:5055–5072Google Scholar
  16. 16.
    Weiss CK, Kohnle MV, Landfester K, Hauk T, Fischer D, Schmitz-Wienke J, Mailänder V (2008) The first step into the brain: uptake of NIO-PBCA nanoparticles by endothelial cells in vitro and in vivo, and direct evidence for their blood–brain barrier permeation. Chem Med Chem 9:1395–1403Google Scholar

Copyright information

© Springer-Verlag/Wien 2010

Authors and Affiliations

  • Hari Shanker Sharma
    • 1
    • 2
    Email author
  • Saber Hussain
    • 3
  • John Schlager
    • 3
  • Syed F. Ali
    • 4
  • Aruna Sharma
    • 1
    • 2
  1. 1.Laboratory of Cerebrovascular Research, Department of Surgical Science, Anesthesiology and Intensive Care MedicineUniversity HospitalUppsalaSweden
  2. 2.Neurochemistry Laboratory, Division of NeurotoxicologyNational Centre for Toxicological Research/FDAJeffersonUSA
  3. 3.Applied Biotechnology Branch, Human Effectiveness Directorate, Air Force Research LaboratoryWright-Patterson Air Force BaseDaytonUSA
  4. 4.Neurochemistry Laboratory, Division of NeurotoxicologyNational Centre for Toxicological Research/FDAJeffersonUSA

Personalised recommendations